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Many misfolded endoplasmic reticulum (ER)
proteins are eliminated by ERAD, a process in
which substrates are polyubiquitylated and
moved into the cytosol for proteasomal degra-
dation. We have identified in S. cerevisiae dis-
tinct ubiquitin-ligase complexes that define dif-
ferent ERAD pathways. Proteins with misfolded
ER-luminal domains use the ERAD-L pathway,
in which the Hrd1p/Hrd3p ligase forms a near
stoichiometric membrane core complex by
binding to Der1p via the linker protein Usa1p.
This core complex associates through Hrd3p
with Yos9p, a substrate recognition protein in
the ER lumen. Substrates with misfolded intra-
membrane domains define a pathway (ERAD-M)
that differs from ERAD-L by being indepen-
dent of Usa1p and Der1p. Membrane proteins
with misfolded cytosolic domains use the
ERAD-C pathway and are directly targeted to
the Doa10p ubiquitin ligase. All three pathways
converge at the Cdc48p ATPase complex.
These results lead to a unifying concept for
ERAD that may also apply to mammalian cells.
INTRODUCTION
Misfolded proteins accumulating in the lumen or mem-
brane of the endoplasmic reticulum (ER) cause the un-
folded protein response (UPR), a collection of signaling
pathways that adapt cells to ER stress (Travers et al.,
2000). If the problem cannot be rectified, these proteins
are eventually transported into the cytosol and degraded
by the proteasome. This process is called ERAD (for ER-
associated protein degradation), retrotranslocation, or
dislocation (Meusser et al., 2005; Tsai et al., 2002), and it
plays a role in many diseases. The mechanism of ERAD
is still largely unknown, but it involves several different
steps (for review, see Meusser et al., 2005; Tsai et al.,2002). The process begins with the recognition of a sub-
strate as being misfolded, likely involving certain chaper-
ones. Next, the substrate is transported across the ER
membrane, a process that, at least for luminal proteins,
probably requires a protein-conducting channel. Once
on the cytoplasmic side of the membrane, most sub-
strates are polyubiquitylated in a process that requires
specific ubiquitin-conjugating and -ligase enzymes. The
polyubiquitin chain is subsequently recognized by a cyto-
solic ATPase complex, consisting of an ATPase, called
p97 or VCP inmammals andCdc48p in yeast, and a hetero-
dimeric cofactor, containing Ufd1p and Npl4p. The hydro-
lysis of ATP is required to move the polypeptide into the
cytosol so that it can be degraded by the proteasome.
Although most ERAD substrates follow this general
scheme, they appear to use distinct pathways, which
are best characterized in S. cerevisiae (Huyer et al.,
2004; Vashist andNg, 2004). Proteins withmisfolded cyto-
solic domains (ERAD-C substrates) are degraded rapidly
and require the ubiquitin ligase Doa10p, a multispanning
membrane protein with a cytosolic RING finger domain
(Swanson et al., 2001). Proteins withmisfolded luminal do-
mains (ERAD-L substrates) are degradedmore slowly and
might have to cycle through the cis-Golgi compartment
before undergoing retrotranslocation at the ER (Caldwell
et al., 2001; Vashist et al., 2001). The recognition of these
substrates involves luminal chaperones, including the
lectin-like proteins Yos9p and Htm1p (Bhamidipati et al.,
2005; Buschhorn et al., 2004; Jakob et al., 2001; Kim
et al., 2005; Szathmary et al., 2005). The ERAD-L pathway
requires the ubiquitin ligase Hrd1p (Der3p) for substrate
polyubiquitylation (Bays et al., 2001; Bordallo et al.,
1998; Hampton et al., 1996). Hrd1p is also amultispanning
membrane protein with a cytosolic RING finger domain; it
is associatedwith Hrd3p, amembrane protein of unknown
functionwith a sizable luminal domain (Gardner et al., 2000).
Both ERAD-C and -L pathways employ the Cdc48p/
Ufd1p/Npl4p ATPase complex and the recently identified
adaptor protein Ubx2p, a membrane protein that binds
Cdc48p through its cytosolic Ubx domain (Neuber et al.,
2005; Schuberth and Buchberger, 2005).
The precise mechanistic differences between the
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number of identified components required for the degra-
dation of various substrates is bewildering and no coher-
ent picture has yet emerged. In addition, the precise func-
tion of many components is unknown and that of others is
controversial. A particularly important issue is the nature
of the protein-conducting channel, which likely is required
for at least soluble ERAD-L substrates. One possibility is
that retrotranslocation occurs through the same Sec61p
channel that is used for the transport of proteins in the
‘‘forward’’ direction, from the cytosol into the ER. How-
ever, the experiments implicating Sec61p in ERAD are
not entirely convincing (for a discussion, see Tsai et al.,
2002), and other candidates have been proposed, includ-
ing the ubiquitin ligase Hrd1p (Gauss et al., 2006) and
Der1p (Lilley and Ploegh, 2004; Ye et al., 2004), a mem-
brane protein that spans the membrane four times (Knop
et al., 1996). In summary, although it is now clear that
ERAD substrates employ different routes, the identifica-
tion of the participating components and their arrange-
ments into pathways remain important issues. In addition,
it is unclear whether proteins with misfolded intramem-
brane domains constitute yet another class of ERAD sub-
strates, and if so, which components are involved.
The situation in mammalian cells is even less clear, al-
though many ERAD components are sequence-related
to yeast proteins. Perhaps the best characterized pathway
is the one in which ERAD is hijacked by the US11 protein
of the human cytomegalovirus to destroy newly synthe-
sized MHC class I heavy chains, allowing the virus to
evade the cellular immune defense. The single-spanning
membrane protein US11 first interacts with the MHC class
I heavy chain in the ER lumen. US11 then interacts with
Derlin-1, a protein with sequence similarity to the yeast
Der1p (Lilley and Ploegh, 2004; Ye et al., 2004). Derlin-1
associates with the ubiquitin ligases Hrd1p and gp78
(Lilley and Ploegh, 2005; Ye et al., 2005), which are both
related to yeast Hrd1p, but these ligases do not seem to
be required for the degradation of MHC class I molecules
(Kikkert et al., 2004). The cytosolic p97 ATPase and its
cofactor Ufd1p/Npl4p are recruited by interactions with
several different membrane proteins, which include Der-
lin-1, the ligases Hrd1p and gp78, and VIMP, a Derlin-1-
associated protein that lacks obvious homologs in lower
eukaryotes (Ye et al., 2004, 2005). Surprisingly, a related
pathway, in which the viral protein US2 triggers the degra-
dation of MHC class I heavy chains, does not seem to
employ Derlin-1 (Lilley and Ploegh, 2004). While cellular
substrates for Derlin-1 have yet to be identified, one
ERAD substrate has been identified that requires the re-
lated proteins Derlin-2 and -3 (Oda et al., 2006). Additional
components may also play a role, although their functions
are even less clear. These include Herp, a membrane pro-
tein that is highly upregulated by the UPR, binds to Hrd1p,
and is required for the degradation of some ERAD sub-
strates (Kokame et al., 2000; Schulze et al., 2005). The ex-
istence of multiple genes for many mammalian compo-
nents, the difficulty to make knockouts in mammalian
cells, and the lack of substrates are among the factors362 Cell 126, 361–373, July 28, 2006 ª2006 Elsevier Inc.that make it difficult to derive a general concept for mam-
malian ERAD.
Here we have taken a systematic approach in S. cerevi-
siae to identify several different ubiquitin-ligase com-
plexes, which define distinct pathways for the degradation
of ER proteins with misfolded domains in the lumen, the
membrane, or the cytosol. The proposed unifying concept
of ERAD may also apply to mammalian cells.
RESULTS
Interaction Partners of the Two ERAD
Ubiquitin Ligases
We performed a systematic analysis of the interactions
of the two major ubiquitin ligases implicated in ERAD in
S. cerevisiae. The ligase Doa10p was C-terminally fused
to a tandem affinity purification (TAP) tag, consisting of
a calmodulin binding peptide and an IgG interaction mod-
ule, separated by a TEV cleavage site (Rigaut et al., 1999).
The tagged protein was expressed from its endogenous
promoter and was functional, as assayed by the degrada-
tion of the standard ERAD-C substrate Ste6-166p (Huyer
et al., 2004; Figure S1). The Doa10p-TAP was isolated
from a crude membrane fraction by solubilization in the
detergent digitonin, followed by affinity purification. Ini-
tially, we employed the usual two-step procedure using
IgG and calmodulin columns, but we noticed that higher
yields could be obtained by single-step purification on
IgG-coupled magnetic beads without compromising the
purity of the samples. The eluted proteins were subjected
to SDS-PAGE and showed several bands that were not
seen in mock-purified samples from wild-type cells
(Figure 1A). Tandem mass spectroscopy identified the
Doa10p-interacting proteins as the ubiquitin-conjugating
enzymeUbc7p and itsmembrane anchor Cue1p (Biederer
et al., 1997), the ATPase Cdc48p, its cofactor Npl4p, and
Ubx2p, a membrane-recruiting factor for Cdc48p. All
these components have been implicated in the degrada-
tion of ERAD-C substrates. Similar results were obtained
by mass spectroscopy of the total population of TAP-pu-
rified proteins, analyzed without separation by SDS-PAGE
(Figures 1B and S2). The composition of the Doa10p com-
plex was confirmed by TAP purification of C-terminally
tagged Ubx2p (Figure 1B), again expressed from its en-
dogenous promoter and fully functional in degrading
a known ERAD substrate (Figure S1). These experiments
suggest that the Doa10p complex is relatively simple, con-
sisting of ubiquitin-conjugating and -ligating enzymes and
the Cdc48p ATPase complex, including its membrane-
recruiting factor Ubx2p.
A similar strategy was followed to identify interaction
partners of the ubiquitin ligase Hrd1p. Hrd1p-TAP was ex-
pressed from its endogenous promoter andwas fully func-
tional in degrading the misfolded luminal protein CPY*, an
ERAD-L substrate (Vashist and Ng, 2004; Figure S1). Sev-
eral Hrd1p-interacting proteins were identified by SDS-
PAGE and mass spectrometry (Figure 2A). As expected,
we found the Hrd1p cofactor Hrd3p (Gardner et al., 2000),
Ubx2p and Cdc48p (Neuber et al., 2005; Schuberth and
Buchberger, 2005), and Der1p (Gauss et al., 2006). In ad-
dition, we identified Yos9p, a lectin-like luminal protein
proposed to deliver substrates to the ERAD machinery
(Bhamidipati et al., 2005; Kim et al., 2005; Szathmary
et al., 2005), and a protein called Usa1p. Usa1p is a mem-
brane protein of 100 kDa of hitherto unknown function
(Awasthi et al., 2001). It is encoded by a nonessential
gene andwill be discussed inmore detail in a later section.
The same binding partners of Hrd1p-TAP were identified
when the proteins eluted from the IgG column were ana-
Figure 1. Ubiquitin Ligase Doa10p-Associated Proteins
(A) TAP-tagged Doa10p (Doa10-TAP) was purified from digitonin-
solubilized membranes using IgG-coupled magnetic beads. SDS-
eluted proteins were separated by SDS-PAGE and stained with
Coomassie blue. A control was performed with wild-type cells (‘‘un-
tagged’’). The identity of the proteins in the bands was determined
by mass spectrometry (Figure S2). Stars indicate the positions of IgG
heavy and light chains.
(B) The network represents a summary of all identified interactions, us-
ing Doa10-TAP, Ubx2-TAP, or Cdc48-TAP as baits. The interaction
partners were pulled down with IgG-coupled magnetic beads and
identified by mass spectrometry without further separation. In the
case of Doa10-TAP, partners were also identified from bands in
SDS-PAGE (see Figures 1A and S2). Arrows point from the bait to
the interaction partner. Components in black and light green indicate
ubiquitin-conjugating and Cdc48p-ATPase complexes, respectively.lyzed without further separation (Figure S2). To confirm
the interactions, we purified TAP fusions of Hrd3p,
Yos9p, Der1p, Usa1p, Ubx2p, and Cdc48p. The tag com-
promised the function of these proteins to varying de-
grees, as assayed by the degradation of CPY* (Figure S1);
the Hrd3p and Der1p fusions were practically nonfunc-
tional. Nevertheless, all tagged proteins were still capable
of interacting with the other components of the complex
(Figure 2B). When the Usa1p-interacting proteins were
separated by SDS-PAGE, all major bands corresponded
to the proteins of the complex (Figure 2C). Usa1p and
Hrd3p have nearly identical sizes, but the TAP-tag on
Usa1p allowed their separation (compare Figures 2A and
2C). From the relative intensities of the Coomassie-
stained bands it appears that Hrd1p, Hrd3p, and Usa1p
are present in near stoichiometric amounts.
For both the Doa10p and Hrd1p complexes, all identi-
fied components were represented by a large set of pep-
tides, which often covered much of the entire protein
sequence (Figure S2). The only exception was Der1p, for
which only a few tryptic peptides were found, in agree-
ment with the predictions from its sequence. Most purifi-
cations were performed at least twice and gave the
same major interaction partners (Figure S2). Contaminat-
ing proteins, on the other hand, were variable and gener-
ally gave only a few peptides. We therefore feel confident
that we have identified most, if not all, components of the
two ubiquitin-ligase complexes. The identification of the
proteins in both Coomassie-stained SDS gels and in un-
fractionated samples also argues that the interactions
among the components are direct rather than mediated
by some unidentified component.
Characterization of the Hrd1p Complex
Given the large number of components interacting with
Hrd1p, we wished to test whether they are all present in
a high-molecular-weight complex. To this end, we used
strains expressing either tagged or endogenous proteins,
isolated membrane fractions, and subjected digitonin ex-
tracts prepared from them to sucrose gradient centrifuga-
tion. Individual fractions were analyzed by immunoblot-
ting. We found that Hrd1p-TAP migrated at a position
corresponding to a molecular weight of >500 MDa (Fig-
ures 3A and S3), much larger than expected from its actual
size. Endogenous Hrd1p sedimented at the same posi-
tion, as determined with Hrd1p antibodies (data not
shown). When SDS was added prior to sucrose gradient
centrifugation, Hrd1-TAP shifted to a much smaller size
(Figure 3B), supporting the idea that Hrd1p is present in
a complex. Hrd3p-13Myc showed a similar profile to
Hrd1p (Figure 3C). In parallel experiments we found that
Der1p-TAP fractionated into two peaks: one matching
that of Hrd1pand theother corresponding to a significantly
smaller size (Figure 3D). The same two populations were
seen with Usa1p-TAP (Figure 3E) or with endogenous
Usa1p (Figure 3F), analyzed by immunoblotting with anti-
bodies raised against the protein. In contrast, Yos9p-
13Myc, which was functional (Figure S1), showed a broadCell 126, 361–373, July 28, 2006 ª2006 Elsevier Inc. 363
Figure 2. Ubiquitin Ligase Hrd1p-Associated Proteins
(A) TAP-tagged Hrd1p (Hrd1-TAP) was purified from digitonin-solubilized membranes using IgG-coupled magnetic beads. SDS-eluted proteins were
separated by SDS-PAGE and stained with Coomassie blue. The bands indicated were not seen in a mock-purification and were identified by mass
spectrometry. Stars (*) indicate the positions of IgG heavy and light chains.
(B) The network represents a summary of all identified interactions, using Hrd1-TAP, Hrd3-TAP, Yos9-TAP, Der1-TAP, Usa1-TAP, Ubx2-TAP, or
Cdc48-TAP as baits. The interaction partners were pulled down with IgG-coupled magnetic beads and identified by mass spectrometry without
further separation. In the case of Hrd1-TAP and Usa1-TAP, partners were also identified from bands in SDS-PAGE (see Figures 2A, 2C and S2).
Arrows point from the bait to the interaction partner. Components in red and light green are in the Hrd1p-core and Cdc48p-ATPase complexes,
respectively.
(C) As in (A), but with Usa1p-TAP as a bait.distribution, with only a small population having a large
size (Figure 3G). Ubx2p-TAP (Figure 3H) or endogenous
Cdc48p (Figure 3I) sedimented almost exclusively at lower
molecular weight fractions, although they did not exactly
comigrate. Components of the 19S regulatory particle of
the proteasome were also found in these fractions (data
not shown). Taken together, these results suggest that
Hrd1p, Hrd3p, Usa1p, and Der1p are present in a large
complex, which we will refer to as the Hrd1p core364 Cell 126, 361–373, July 28, 2006 ª2006 Elsevier Inc.complex. Mammalian Hrd1p is also in a large complex
(Schulze et al., 2005). The other proteins detected in the
pull-down experiments (Yos9p, Ubx2p, and Cdc48p)
could either be present in excess of the core components
or have a lower affinity to them. The size of the core com-
plex appears to be larger than expected from the sum of
the molecular weights of the constituents, suggesting
that some components may be present in more than one
copy, consistent with reports that the mammalian
Figure 3. Characterization of the Hrd1p
Complex by Sucrose Gradient Centrifu-
gation
Digitonin-solubilized membrane fractions de-
rived from cells expressing various tagged pro-
teinswere subjected to centrifugation in a linear
5%–30% sucrose gradient. Fractions were col-
lected and analyzed by immunoblotting with
antibodies directed against the tags or the en-
dogenous proteins (in the case of Usa1p and
Cdc48p). Stars (*) indicate a nonspecific band
recognized by the Usa1p antibodies.homologs of Der1p form homo-oligomers (Lilley and
Ploegh, 2005; Ye et al., 2005).
Usa1p: A Novel ERAD-L Component
Although Usa1p had not previously been described as an
ERAD component, it has been found in genome-wide
screens to be highly upregulated by the UPR (Travers
et al., 2000). Usa1p is predicted to be a double-spanning
membrane protein with both N and C termini in the cyto-
sol, and it has an ubiquitin-like (Ubl) domain in its N-termi-
nal cytosolic domain (Figure 4A).
To investigate whether Usa1p has a function in ERAD,
we first tested whether the lack of Usa1p compromises
the viability of cells that cannot elicit the UPR, as has
been observed with other ERAD components (Ng et al.,
2000). While cells lacking Ire1p, a key component of the
UPR, or cells lacking Usa1p, grew normally at all temper-
atures tested, a mutant lacking both Ire1p and Usa1p had
a severe growth defect at higher temperatures (Figure 4B).
Thus, as with other ERAD components, Usa1p becomes
essential under stress conditions in cells that cannot elicit
the UPR.
Next we compared the degradation kinetics of several
ERAD substrates in wild-type and USA1 deletion cells
(Figure 4C). The degradation rates of the ERAD-L sub-
strates KHN, a luminal protein, and of KWW, a membrane
protein with a misfolded luminal domain (Vashist and Ng,
2004), were greatly reduced in the absence of Usa1p.
The effect was as strong as seen in the absence of
Yos9p or Hrd1p. In mutant cells, the molecular weights
of the stabilized proteins increased by O-glycosylation
(Figure 4C), either in the ER or after export by vesicular
trafficking (Vashist et al., 2001). The degradation of the
ERAD-L substrate CPY* was also greatly affected in the
absence of Usa1p (see below). In contrast, the degrada-tion of the ERAD-C substrate Ste6-166 was not affected
by the deletion of USA1. Controls showed that, as ex-
pected (Huyer et al., 2004), DOA10 deletion stabilized
this substrate (Figure 4D). Thus, in agreement with our ob-
servation that Usa1p is associated with known ERAD-L
components, Usa1p is functionally required for the
ERAD-L but not the ERAD-C pathway.
Yeast Usa1p does not have obvious sequence relatives
in higher eukaryotes, but the mammalian Herp protein
might perform an analogous function. Like Usa1p, Herp
spans the membrane twice and has an N-terminal Ubl do-
main. It is highly upregulated by UPR, is associated with
Hrd1p and Derlin-1, and is required for the degradation
of some ERAD substrates (Kokame et al., 2000; Schulze
et al., 2005). Consistent with these similarities, we found
that the expression ofmammalian Herp in aUSA1 deletion
strain of S. cerevisiae partially restored the degradation of
CPY* (Figure 4E) and of KWW (Figure S4).
Hrd1p Is Involved in ERAD-L and ERAD-M Pathways
Although Hrd1p is present in a large core complex (Fig-
ure 3), data in the literature suggest that somecomponents
may not be required for the degradation of all substrates.
For example, while Hrd1p is essential for the degradation
of Hmg2p or a mutant version of Pdr5p (Pdr5*), Der1p
appears to be dispensable in both cases (see Brodsky
and McCracken, 1999). These data suggest that Hrd1p-
dependent ERAD substrates fall into different classes. To
test this idea,we examined a number of knownHrd1p sub-
strates for their requirement of the Hrd1p-associated pro-
teins. In agreement with the literature, we found that the
ERAD-L substrates CPY*, KWW, and KHN, as well as the
membrane proteins Hmg2p, Sec61-2, and Pdr5*, which
have not yet been classified, are all dependent on Hrd1p
for their degradation (Figure 5A and data not shown; forCell 126, 361–373, July 28, 2006 ª2006 Elsevier Inc. 365
Figure 4. Characterization of the Novel ERAD Component Usa1p
(A) Scheme of the predictedmembrane topology and domain structure of Usa1p. Transmembrane segments are shown in black and theUbl domain is
indicated.
(B) Wild-type (wt) cells or cells carrying deletions in USA1 (usa1D), IRE1 (ire1D), or both (usa1D ire1D) were plated on rich medium and incubated at
37C for 2 days.
(C) To test the degradation of the two ERAD-L substrates KHN and KWW, wild-type (wt) cells or cells carrying the indicated deletions were pulse-
labeled with 35S-methionine/cysteine and chase-incubated for different time periods. The samples were analyzed by immunoprecipitation, SDS-
PAGE, and autoradiography. Densitometry of the bands was used to quantify the data (right panels).
(D) To test the degradation of the ERAD-C substrate Ste6-166, wild-type (wt) cells or cells carrying the indicated deletions were analyzed as in (C).
(E) The degradation of the ERAD-L substrate CPY* was tested in usa1D cells carrying plasmids coding for Usa1p or mammalian Herp. An empty vec-
tor was used as a control. Protein degradation was followed by immunoblotting after inhibition of protein synthesis with cycloheximide. The bands
were quantitated by densitometry (right panel).366 Cell 126, 361–373, July 28, 2006 ª2006 Elsevier Inc.
a summary, see Table 1). The absence of Der1p affected
CPY*, KHN, and KWW but not Hmg2p, Sec61-2, and
Pdr5*, as reported before for some of these proteins. The
absence of Usa1p had the same effect as that of Der1p;
it affected the ERAD-L substrates CPY*, KHN, and KWW
Table 1. Genetic Requirements for the Degradation
of Several ERAD Substrates
ERAD-M
ERAD-L
Substrates HRD1 HRD3 USA1 DER1
CPY* + + + +
KHN + n.d. + +
KWW + n.d. + +
Sec61-2 + +  
Hmg2 + +  
Pdr5* + +  
CD4 + + n.d. 
(n.d.) is not determined.but not Hmg2p, Sec61-2p, and Pdr5* (Figures 4C, 5A,
5B, and S5). Hmg2p, Sec61p-2p, and Pdr5* thus appear
to belong to a separate class of ERAD substrates.
Hmg2p has a misfolded intramembrane domain in the
presence of farnesol (Shearer and Hampton, 2005),
Sec61-2p is probably defective inside the membrane
since the components of the Sec61p complex do not
have significant luminal domains (Van den Berg et al.,
2004), andPdr5* is amultispanning proteinwith amutation
close to the membrane in a predicted luminal loop. We
therefore propose that these ERAD substrates are mis-
folded inside the membrane and use a pathway, desig-
nated ERAD-M, that requires Hrd1p but not Der1p or
Usa1p.
Usa1p Provides a Link between Hrd1p and Der1p
Because Hrd1p is involved in both ERAD-L and -M, while
the other membrane proteins of the core complex Usa1p
and Der1p are only required for ERAD-L, we tested how
these components are associated with one another.
DER1 deletion did not affect the interaction between
Hrd1p and Usa1p, as determined by sucrose gradient
centrifugation (Figures 5C and S6) and by TAP purificationFigure 5. Distinct Hrd1p-Dependent ERAD Pathways
(A) The degradation of the ERAD-L substrate CPY* was analyzed by immunoblotting in wild-type (wt) cells or cells carrying deletions of the indicated
genes, following inhibition of translation with cycloheximide. The bands of the experiment shown in Figure S5 were quantitated by densitometry.
(B) The degradation of misfolded integral membrane proteins was analyzed as in (A).
(C) Digitonin-solubilizedmembrane fractions derived fromwild-type cells or cells lacking Usa1p, Der1p, or Yos9p were subjected to sucrose gradient
centrifugation, and fractions were immunoblotted for Hrd1-TAP as in Figure 3.
(D) Hrd1-TAP was purified on IgG-coupled magnetic beads from wild-type cells or cells lacking Usa1p, and the interaction partners were determined
by SDS-PAGE followed by staining with Coomassie blue. The highlighted region was analyzed by mass spectrometry and showed the presence of
Der1p only in the sample derived from wild-type cells. Stars indicate the positions of IgG heavy and light chains.Cell 126, 361–373, July 28, 2006 ª2006 Elsevier Inc. 367
Figure 6. The Luminal Domain of Hrd3p Interacts with Yos9p
(A) Scheme of Hrd3p and of fragments tested for interaction with Yos9p. TM, transmembrane segment; Cyt, cytosolic domain. First and last amino
acids are indicated by numbers.
(B) Myc-tagged constructs of full-length Hrd3 or of the fragments shown in (A) were expressed under the endogenous promoter together with HA-
tagged Yos9p, also expressed from its endogenous promoter. Cell lysates in digitonin were subjected to immunoprecipitation with HA antibodies and
analyzed by SDS-PAGE, followed by immunoblotting with Myc or HA antibodies. T and S represent 7% of the total extract and supernatant, respec-
tively, and IP is the immunoprecipitate. Here,16%Yos9p-HA precipitated6%of full-length Hrd3p,23%Yos9p-HA precipitated6%of Hrd3 (1–
767), and 37% Yos9p-HA precipitated <1% of Hrd3 (1–392).
(C) TAP-tagged constructs of Hrd3p were expressed under the endogenous promoter together with HA-tagged Yos9p. Immunoprecipitation was
performed with IgG beads, and analysis was done by immunoblotting with HA antibodies or with IgG. T and S represent 10% of the total extract
and supernatant, respectively, and IP is the immunoprecipitate. Star (*) indicates the position of IgG heavy chain. Here, 21% Hrd3p-TAP, 15%
Hrd3 (1–767)-TAP, and 25% Hrd3 (1–392)-TAP precipitated 12%, 14%, and 4% of Yos9p, respectively.
(D) As in (C), but both the Hrd3p constructs and Yos9-Myc were overexpressed under the Gal promoter for 4 hr. T and S represent 10% of the total
extract and supernatant, respectively, and IP is the immunoprecipitate. Here,14%Hrd3p-TAP,13%Hrd3 (1–767)-TAP, and15%Hrd3 (1–392)-
TAP precipitated 9%, 16%, and 5% of Yos9p, respectively.of Hrd1p, followed by mass spectroscopy (data not
shown). On the other hand, deletion of USA1 resulted in
a shift of Hrd1p in sucrose gradients to low molecular
weight fractions (Figure 5C). Furthermore, when Hrd1p-
TAP was purified from cells lacking Usa1p, Der1p was
no longer copurified (Figure 5D). These data suggest
that Usa1p recruits Der1p to the ubiquitin ligase Hrd1p.
Yos9p Interacts with the Luminal Domain of Hrd3p
Next we wished to analyze how Yos9p, the only luminal
protein in the Hrd1p interaction network (Figure 2), is re-
cruited to the ER membrane. We suspected that Hrd3p368 Cell 126, 361–373, July 28, 2006 ª2006 Elsevier Inc.is the binding partner because it has by far the largest lu-
minal domain among the components of the Hrd1p core
complex. Indeed, endogenously expressed Yos9p-3HA
pulled down Myc-tagged luminal segments of Hrd3p (Fig-
ures 6A and 6B). Conversely, TAP purification of tagged
luminal segments of Hrd3p resulted in the copurification
of Yos9p-3HA (Figure 6C). With the entire luminal domain
of Hrd3p, the interaction was as strong as with full-length
Hrd3p, whereas a much weaker interaction was detected
with an N-terminal fragment of the luminal domain. The in-
teraction between the luminal domain of Hrd3p and Yos9p
is probably direct, because it was observed when both
Figure 7. Distinct Ubiquitin-Ligase Com-
plexes Defining Different ERAD Path-
ways
(A) The scheme shows the ubiquitin-ligase
complexes involved in the ERAD-L, -M, and -C
pathways. Components in orange and green
belong to the Hrd1p core and Cdc48p ATPase
complexes, respectively. Stars show the loca-
tion of the misfolded domain of a substrate.
Ub is ubiquitin.
(B) Mammalian homologs or functional equiva-
lents of the components of the yeast ubiquitin-
ligase complexes. Question marks (?) indicate
uncertainty.partners were highly overexpressed (Figure 6D). These
results suggest that the luminal substrate recognition pro-
tein Yos9p delivers its ERAD-L cargoes to the Hrd1 core
complex via Hrd3p.
DISCUSSION
We have performed a systematic mapping of interactions
between ERAD components in S. cerevisiae, which re-
sulted in the identification of most, if not all, components
of two distinct ubiquitin-ligase complexes. The complex
involving the Hrd1p ubiquitin ligase defines the entire
ERAD-L pathway bywhich proteins withmisfolded luminal
domains are degraded. Only a subset of the components
of the Hrd1 complex is required for the degradation of
some membrane protein substrates, and these appear
to use a novel pathway, ERAD-M, by which proteins with
misfolded intramembrane domains are destroyed. Finally,
we identified a complex involving the ubiquitin ligase
Doa10p, which defines the ERAD-C pathway that elimi-
nates membrane proteins with misfolded cytosolic do-
mains. The proposed classification is still somewhat pre-
liminary, as it is based on a small number of substrates
for each pathway. In addition, proteins might have mis-
folded domains in more than one location, or the folding
of one domain could influence that of another. One
ERAD pathway may therefore be dominant over another,as demonstrated for ERAD-C over ERAD-L (Vashist and
Ng, 2004), or, in other cases, they might be operating in
parallel. It should also be noted that the deletion of most
ERAD components does not lead to a complete block of
degradation, perhaps because substrates can use an
‘‘overflow’’ pathway involving transport via the Golgi to
the vacuole/lysosome (Haynes et al., 2002; Spear and
Ng, 2003). Despite these caveats, our results and a large
number of data in the literature suggest a simple, unifying
concept for ERAD (Figure 7).
The ERAD-L Pathway
As might have been expected, ERAD-L is the most com-
plex pathway, used by substrates with misfolded ER lumi-
nal domains, be they in soluble or in membrane proteins.
These substrates require a core membrane complex,
consisting of the ubiquitin ligase Hrd1p and its cofactors
Hrd3p, Der1p, and Usa1p. These components form
a near stoichiometric complex that is more loosely associ-
ated with the luminal Yos9p and the cytosolic Cdc48
ATPase complex, whose membrane recruitment is facil-
itated by Ubx2p (Figure 7A).
Yos9p binds misfolded glycoprotein substrates in the
ER lumen and may be involved in the initial recognition
of at least some ERAD-L substrates (Bhamidipati et al.,
2005; Buschhorn et al., 2004; Kim et al., 2005; Szathmary
et al., 2005). Yos9p would transfer its cargo to the Hrd1pCell 126, 361–373, July 28, 2006 ª2006 Elsevier Inc. 369
core membrane complex, mediated by the demonstrated
interaction between Yos9p and Hrd3p. All ERAD-L sub-
strates tested by us are glycoproteins, and it is therefore
unclear whether nonglycosylated proteins would employ
Yos9p aswell. Other luminal factors, such as protein disul-
fide isomerase or Htm1p, could also play a role in sub-
strate recognition and might deliver their substrates
directly to the Hrd1p core complex (Gillece et al., 1999;
Jakob et al., 2001). In fact, while cells lacking Hrd3p can-
not degrade CPY*, this can be overcome by overexpres-
sion of Hrd1p (Plemper et al., 1999), supporting the idea
that the Hrd1p core complex can accept substrates
from multiple delivery routes, probably by binding to
Der1p (Gauss et al., 2006).
In the next step, an ERAD-L substrate must be moved
through the membrane, likely through a protein-conduct-
ing channel. Possible components of the channel are
Der1p and Usa1p because they are only required for
substrates with misfolded luminal domains. However,
the six transmembrane segments of Hrd1p may also con-
tribute to the formation of a channel. We have not found
the Sec61p complex among the interaction partners of
ERAD components, and we consider it unlikely that the
Sec61p channel is used for ERAD-L substrates because
the structure of an archael homolog shows that a ‘‘plug’’
would obscure the access of substrates from the luminal
side (Van den Berg et al., 2004).
Because soluble and membrane bound ERAD-L sub-
strates follow the same pathway, we postulate that in
the case of amembrane protein, themisfolded luminal do-
main moves through the channel before the membrane-
anchored portion is released into the cytosol. Once a seg-
ment of the luminal domain of an ERAD-L substrate
emerges into the cytosol, it is polyubiquitylated by the
ligase Hrd1p. Our interaction mapping supports the previ-
ous conclusion that the ligase cooperates with the ubiqui-
tin-conjugating enzyme Ubc7p and its membrane anchor-
ing protein Cue1p (Biederer et al., 1997; Bordallo et al.,
1998). The polyubiquitin chain probably serves both as
a ratcheting device, preventing substrate movement
back into the ER lumen and as a signal for downstream
ubiquitin binding proteins (Flierman et al., 2003).
A critical role of the newly discovered Usa1 protein ap-
pears to be as a link between Hrd1p and Der1p in the core
complex. Usa1p was found as a prominent interaction
partner of all ERAD-L components. It was also detected
as a partner of Hrd1p in recent proteomic experiments
(Gavin et al., 2006). Usa1p is required for all tested
ERAD-L substrates but not for substrates of the other
two pathways.
Once polyubiquitylated, a substratemust bemoved into
the cytosol, likely by the Cdc48p ATPase complex, con-
sisting of Cdc48p itself and the cofactor Ufd1p/Npl4p. Re-
cruitment of the ATPase complex to the membrane prob-
ably occurs by several different interactions, with Ubx2p
providing a major link through its Ubx domain (Neuber
et al., 2005; Schuberth and Buchberger, 2005). Ubx2p
spans the membrane twice and has an Uba domain370 Cell 126, 361–373, July 28, 2006 ª2006 Elsevier Inc.(Schuberth and Buchberger, 2005). How Ubx2p is re-
cruited to the Hrd1p core complex is unknown, but it
may involve an interaction with the polyubiquitylated sub-
strate through its Uba domain (Gauss et al., 2006; Neuber
et al., 2005), similar to the interaction between the Uba do-
main in Rad23p and polyubiquitin chains (Richly et al.,
2005). The ATPase complex also interacts with sub-
strate-attached polyubiquitin chains (Ye et al., 2003). In
addition, from results in mammalian systems it seems
possible that Cdc48p interacts directly with the C termini
of Der1p and Hrd1p (Ye et al., 2005). Finally, Cdc48p
may interact with unfolded segments of the substrate,
independently of its polyubiquitin chain (Ye et al., 2003).
These multiple interactions would allow the recruitment
of the ATPase complex, which in turn would move the
substrate into the cytosol for proteasomal degradation.
The ERAD-M Pathway
Data in the literature and our own results indicate that
some membrane proteins require for its degradation
Hrd1p and Hrd3p, but not the other components of the
Hrd1p core complex (Table 1). Although based on a small
number of examples, the common feature of these sub-
strates might be a misfolded intramembrane domain.
We thus propose that they are degraded by a novel path-
way called ERAD-M (Figure 7A). Because Hrd1p and
Hrd3p were detected in a single complex, it is possible
that the same core complex is employed in both ERAD-M
and ERAD-L, although only a subset of the components
is functionally required for ERAD-M. Substrates of the
ERAD-M pathway may be targeted to the ubiquitin ligase
Hrd1p by Yos9p, as is the case for the glycosylated sub-
strate Pdr5*, or by other factors that are too loosely asso-
ciated to be detected by pull-down experiments. Alterna-
tively, substrates can be targeted directly to Hrd1p, as
suggested for Hmg2p by crosslinking experiments (Gard-
ner et al., 2001). The remainder of the pathway would be
similar to that of ERAD-L substrates, employing the
Cdc48p ATPase complex and the adaptor Ubx2p. Inter-
estingly, ERAD-M substrates do not require the Usa1p
andDer1p, two possible channel components. Theymight
either use a smaller channel consisting of Hrd1p alone or
directly be extracted from the membrane, as proposed
for the bacterial FtsH protein (Akiyama and Ito, 2003).
FtsH is an innermembrane protein consisting of two trans-
membrane segments, an ATPase domain, and a protease
domain. It binds to a relatively short cytosolic segment of
a misfolded membrane protein, pulls it out of the mem-
brane, and degrades it in a processive fashion. It should
be noted that Der1p is required for the degradation of
Hrd1p in cells lacking Hrd3p even though Hrd1p does
not have a sizable luminal domain (Plemper et al., 1999),
but it is unclear whether unstable ERAD components
can be considered normal ERAD substrates.
The ERAD-M pathway might be dominant over the
ERAD-L pathway. The addition of a transmembrane seg-
ment to CPY* converts it into a Der1p-independent
ERAD-M substrate (Taxis et al., 2003), and themammalian
protein CD4 is degraded in S. cerevisiae in a Der1p-
independent manner even though it has a sizable luminal
domain (Meusser and Sommer, 2004). These might be
examples where a misfolded luminal domain causes mis-
folding inside the membrane, or the transmembrane
segments might have unusual structures (one segment
contains five glycines, the other four tyrosines). In contrast
to ERAD-L substrates, the membrane-anchored portion
might move into the cytosol before the luminal domain,
which would make the ERAD-M pathway dominant.
The ERAD-C Pathway
This pathway takes care of membrane proteins with mis-
folded cytosolic domains. They appear to be handled in
a similar way as ERAD-M substrates, except that they
use a different ubiquitin ligase, Doa10p (Figure 7A). Again,
substrates may be targeted to the ligase and then moved
into the cytosol by the Cdc48p ATPase complex, recruited
by Ubx2p. Doa10p can also polyubiquitylate cytosolic and
nuclear substrates, so it may be less dedicated to ERAD
than Hrd1p (Neuber et al., 2005; Ravid et al., 2006; Swan-
son et al., 2001). Since proteins with misfolded domains
on both sides of the membrane are degraded by the
ERAD-C pathway (Vashist and Ng, 2004), we again hy-
pothesize that the membrane-anchored domain is moved
into the cytosol before the misfolded luminal domain.
Mammalian ERAD Pathways
We propose that the same three ERAD pathways operate
in mammalian cells. As indicated in Figure 7B, there are
mammalian homologs of all ERAD components identified
in yeast.We showhere that themammalian Herp protein is
the functional equivalent to yeast Usa1p even though it
does not show significant sequence similarity and is
much longer. During evolution, several ERAD components
appear to have multiplied and diverged, and they may be
required for distinct substrates in mammalian cells. For
example, the ligase gp78, but not its cousin Hrd1p, is re-
quired for the degradation of mammalian HMG-CoA re-
ductase (Song et al., 2005), and Derlin-2 and -3, but not
Derlin-1, are required for the degradation of the NHK pro-
tein (Oda et al., 2006). In addition, higher eukaryotes pos-
sess additional membrane bound ubiquitin ligases with
RING finger domains, and these might have a function in
the degradation of some ERAD substrates. Despite this
diversification, the mammalian pathways may be funda-
mentally the same as in yeast. A central role for the
Cdc48p ATPase homolog p97 and its cofactor Ufd1/
Npl4 is indeed likely. The best characterized mammalian
pathway, the viral US11 protein-triggered degradation of
MHCclass I heavy chains, fits the proposed scheme (Lilley
and Ploegh, 2005; Ye et al., 2005): US11 specifically
targets its substrate to the ERAD-L pathway, probably re-
placing the function of cellular Yos9p homologs, by bind-
ing to the Derlin-1 protein and a ubiquitin ligase. Because
US2-dependent degradation appears to be independent
of Derlin-1, it seems possible that it sends MHC class I
heavy chains to the ERAD-M pathway. In mammals, butnot in yeast, the targeting of HMG-CoA reductase to the
gp78 ligase and p97 ATPase complex appears to be me-
diated by INSIG, which binds the substrate in a sterol-
dependent manner (Flury et al., 2005; Song et al., 2005).
These results indicate that in mammals there are addi-
tional pathways by which ERAD substrates are recog-
nized, but the core machinery may be conserved among
all eukaryotes.
EXPERIMENTAL PROCEDURES
Yeast Strains and Plasmids
Tagging of proteins and gene deletions were performed using stan-
dard PCR-based homologous recombination. The strains used are
isogenic to BY4730 (Mata ura3D0 his3D1 leu2D0 met15D0) and are
given in Table S7. Details on the plasmids coding for Usa1p
(pPC254) and FLAG-Herp (pPC290) are available in the Supplemental
Data section.
Protein Purification
The membranes of 15 g of cells were sedimented and solubilized in
lysis buffer containing 1% digitonin. The extract was incubated with
either IgG agarose beads (Pharmacia) or with IgG-coupled magnetic
beads (Dynal) for 3–4 hr. After washing, the bound proteins were eluted
with either TEV protease (Rigaut et al., 1999) or by SDS, respectively.
The TEV-eluted proteins were bound to a calmodulin column (Pharma-
cia) and, after washing, elution was performed with EGTA. Eluted pro-
teins were analyzed by SDS-PAGE, and individual bands were excised
and subjected to mass spectrometry. Alternatively, the total popula-
tion of eluted proteins was precipitated with trichloroacetic acid and
analyzed by mass spectrometry. Details of the purification are given
in the Supplemental Data section.
Antibodies to Usa1p
Polyclonal antibodies were raised by Zymed in rabbits against a car-
rier-conjugated peptide corresponding to the C terminus of Usa1p
(positions 820–838).
Immunoprecipitation
Crude membrane fractions were prepared from 100 ml cultures. The
membranes were solubilized in digitonin, as for TAP purification, and
proteins were subjected to immunoprecipitation with either HA anti-
bodies or IgG, both covalently coupled to beads. After washing, the
bound proteins were eluted with SDS, separated by SDS-PAGE, and
analyzed by immunoblotting with antibodies to HA or Myc, or with IgG.
Sucrose Gradient Centrifugation
Crude membrane fractions were prepared from 100 ml cultures. The
membranes were solubilized in digitonin, as for TAP purifications,
and the extract (0.3 ml) was applied to a 5%–30% linear sucrose gra-
dient, generated with a Biocomp gradient maker. Centrifugation was
performed at 50 K in a SW55 rotor (Beckman) for 4 hr at 25C. Frac-
tions (0.25 ml) were collected from the top and analyzed by SDS-
PAGE and immunoblotting.
ERAD-Substrate Degradation Experiments
Plasmids coding for the ERAD substrates were generous gifts from R.
Hampton, S. Jentsch, S. Michaelis, D. Ng, and D. Wolf. Cycloheximide
shut-off experiments were performed in exponentially growing cells,
as described (Gardner et al., 2000). Pulse-chase experiments were
performed in exponentially growing cells, as described (Vashist and
Ng, 2004).Cell 126, 361–373, July 28, 2006 ª2006 Elsevier Inc. 371
Supplemental Data
Supplemental Data include six figures, one table, and some experi-
mental procedures and can be found with this article online at http://
www.cell.com/cgi/content/full/126/2/361/DC1/.
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